Human care company Elekta AB (STO:EKTAB.ST) on Friday announced that the Odette Cancer Centre at Sunnybrook Health Sciences Centre, Totonto, has treated its first patient using Elekta Unity on 15 August 2019.

Reportedly, the patient is receiving treatment for a glioblastoma brain tumour.

According to the company, Elekta Unity is a transformative magnetic resonance radiation therapy (MR/RT) system that enables personalised precision radiation therapy. Elekta Unity combines a state-of-the-art 1.5T MRI scanner, a best-in-class 7 MV linear accelerator and breakthrough real-time adaptive radiotherapy software.

The combination of these technologies allows the radiation dose to be reshaped based on daily changes in shape, size and position of the tumour and surrounding healthy anatomy, as visualized with MRI and then enables accurate dose delivery with real-time visualisation of the tumour.

Elekta Unity had received clearance from the Canadian Nuclear Safety Commission just a few weeks ago.

Elekta Unity has CE-mark and 510(k) clearance and is not commercially available in all markets.

Elekta is a leader in precision radiation medicine.